Ekta Batra
Anchor and Associate Editor Research at CNBC-TV18
Editor, Pharmaceutical and Health, CNBC TV18. Reporting, Analysing Pharma & Health since 2008. Tweets personal. Coffee & puppy addict. Myopic bt not in my views
Articles
-
1 week ago |
topologypro.one | Ekta Batra
Shares of Divi's Laboratories Ltd. gained on Wednesday, June 18, following reports of Novartis and MSN settling the 659 patent with regards to heart failure treatment drug Entresto. Divi's Laboratories is expected to be a key supplier of active pharmaceutical ingredients (APIs for Entresto to Novartis). The patent battleAs per reports, the legal battle between Novartis and MSN is expected to move to the next patent, which expires in November 2026 and the related exclusivity expires in May 2027.
-
1 month ago |
topologypro.one | Ekta Batra
Shares of Lupin Ltd shares gained nearly 4% on Tuesday, May 13, as the pharma company launched the Tolvaptan tablets or Jynarque generic in the US market. Axis Capital said Lupin is expected to be the only generic player for the most of the financial year 2026. The company's revenue opportunity for the ongoing fiscal is estimated at $150 million to $200 million.
-
1 month ago |
topologypro.one | Ekta Batra
Piramal Pharma Ltd. shares are in focus on Tuesday, May 13, after the company on Monday said it is investing $90 million for the expansion of its Lexington and Riverview facilities in the US. The company said the expansion is aligned with the growing US customer demand and onshoring of drug supply. The Lexington facility will add 24,000 square feet of sterile injectable manufacturing space, etc. It is expected to be completed by late 2027.
-
Oct 2, 2024 |
cnbctv18.com | Ekta Batra
A recent research highlighted serious health concerns regarding black-coloured plastic kitchen utensils, which may contain alarming levels of toxic flame retardants.
-
May 20, 2024 |
cnbctv18.com | Ekta Batra
Vaccine manufacturer Serum Institute of India has begun exports of the 'R21/Matrix-M' malaria vaccine to Africa. The vaccine is developed in collaboration with the University of Oxford and Novavax’s Matrix-M adjuvant.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 72K
- Tweets
- 6K
- DMs Open
- No
RT @CNBCTV18News: #OnCNBCTV18 | Dr Reddy's Lab (@drreddys) gaining after a bullish note by HSBC. The brokerage upgrades the stock to a Buy…
RT @CNBCTV18News: #StocksInNews | Pharma stocks like Dr Reddy's Lab, Lupin & Zydus Life rise on the back of positive brokerage notes. Wockh…
Insightful perspective
#Semaglutide Sales Barred | Delhi High Court has restrained Dr Reddy’s (@drreddys) and OneSource Specialty from selling #Semaglutide in the domestic market following a patent infringement plea by Novo Nordisk (@novonordisk). ‘Dr Reddy’s will continue to export the drug as they